Canadian regulators approve Covidien's imaging agent

07/6/2009 | American City Business Journals

Health Canada has approved Covidien's abbreviated new drug submission for its kit used in preparing Technetium Tc 99m Sestamibi Injection, a generic version of Dupont's Cardiolite. With the approval, Covidien said it could have the myocardial perfusion imaging agent on the Canadian market this summer.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN